JBC Biosymposia, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Surette, M. G.
Right arrow Articles by Stock, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Surette, M. G.
Right arrow Articles by Stock, J. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 30, Issue of July 26, 1996 pp. 17966-17973
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Role of alpha -Helical Coiled-coil Interactions in Receptor Dimerization, Signaling, and Adaptation during Bacterial Chemotaxis*

(Received for publication, February 28, 1996, and in revised form, April 19, 1996)

Michael G. Surette and Jeffry B. Stock Dagger

From the Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Note Added in Proof
REFERENCES


ABSTRACT

The aspartate receptor, Tar, is a member of a large family of signal transducing membrane receptors that interact with CheA and CheW proteins to mediate the chemotactic responses of bacteria. A highly conserved cytoplasmic region, the signaling domain, is flanked by two sequences, methylated helices 1 and 2 (MH1 and MH2), that are predicted to form alpha -helical coiled-coils. MH1 and MH2 contain glutamine and glutamate residues that are subject to deamidation, methylation, and demethylation. We show that the signaling domain is an independently folding unit that binds CheW. When expressed in vivo the signaling domain inhibits CheA kinase activity, but if MH1 or an unrelated leucine zipper coiled-coil sequence is attached to the signaling domain, CheA is activated. A construct that contains a leucine zipper fused to MH1-signaling domain-MH2 also activates the kinase, both in vivo and in vitro, and this activation is regulated by the level of glutamate modification. These findings support a model for receptor signaling where aspartate binding controls the relative orientation of receptor monomers to favor the formation of coiled-coils between MH1 and/or MH2 between subunits. Glutamate modification may stabilize these coiled-coils by reducing electrostatic repulsion between helices.


INTRODUCTION

The responses of eukaryotic cells to extracellular signals such as cytokines and insulin are generally mediated by transmembrane receptor proteins with extracellular sensory domains that are connected via a single alpha -helical transmembrane sequence to an intracellular signaling domain. Although these proteins have widely divergent sequences, considerable evidence suggests that they share a common mechanism of transmembrane signaling. The binding of stimulatory ligands to the extracellular sensory domains is thought to induce monomer to dimer transitions (1, 2). This facilitates dimer interactions in the intracellular signaling portions of the proteins that lead to the generation of a response. Hormone-induced receptor polymerization has been demonstrated in a number of instances, and the x-ray crystal structure of the extracellular sensory portion of the human growth factor receptor indicates a single asymmetric hormone binding site between monomers in a receptor homodimer (3). Moreover, for several different types of signaling domains, including those with tyrosine kinase and guanylyl cyclase activities, it has been shown that activation requires dimer interactions (2).

Bacteria also have membrane receptors with transmembrane sequences that connect extracellular sensing domains to intracellular signaling domains (4, 5, 6, 7). The membrane topology in bacteria differs slightly from that of most eukaryotic transmembrane receptors in that N-terminal signal sequences that function during protein synthesis to direct the receptors to the membrane are generally removed from eukaryotic receptors, but not from their bacterial counterparts, so that the bacterial proteins have two transmembrane sequences per monomer, whereas the eukaryotic receptors only have one. By far the best characterized bacterial membrane receptor is the protein, designated Tar,1 that mediates Escherichia coli and Salmonella typhimurium chemotaxis responses to aspartate. Tar has been shown to form a homodimer that is stabilized by aspartate binding (8). Each Tar monomer is composed of a periplasmic aspartate binding domain attached by a membrane-spanning hydrophobic sequence to a cytoplasmic signaling region (Fig. 1). The x-ray crystal structure of the ligand binding domain has been solved both in the presence and absence of aspartate (9, 10, 11). It is essentially a dimer of two four helix bundles that bind aspartate at the subunit interface. The first transmembrane helix of each monomer, TM1, is thought to be continuous with the first alpha -helix of the ligand binding domain, and the last alpha -helix of this domain is thought to be continuous with the transmembrane helix that leads to the cytoplasm, TM2 (9, 12). Thus, the structural studies of the bacterial receptor are consistent with a model for stimulus-response coupling that is similar to the mechanism of action that has been proposed for single transmembrane receptors in eukaryotic cells with stimulatory ligand binding causing receptor dimerization and thereby leading to a response. Several lines of evidence argue strongly against the idea that Tar activity is regulated by receptor dimerization, however.


Fig. 1. Schematic representation of the domain organization of the Tar receptor and the Tar protein fragments used in this study. The residues defining regions or fragments are indicted above. Additional residues at the N terminus or between added motifs are indicated by single letter amino acid code. Plasmids expressing these fragments are outlined in Table I.
[View Larger Version of this Image (23K GIF file)]

Tar signals through a protein kinase, CheA, by controlling the rate at which CheA autophosphorylates at a histidine residue (13, 14). The kinase has a multidomain structure with distinct catalytic and phosphoaccepting domains (15, 16), and autophosphorylation involves the kinase domain of each subunit within a dimer catalyzing the phosphorylation of a histidine in the opposing subunit (17, 18). Isolated CheA is in equilibrium between an inactive monomer and an active dimer (19), and CheA dimers form a stable complex with dimeric Tar (20). Complex formation requires binding of a third protein, CheW (20, 21). Rates of CheA dimer autophosphorylation within this ternary complex are either inhibited or stimulated, depending on the signaling state of the receptor (14, 13, 22). Aspartate binding does not appear to affect the stability of the receptor-CheW-CheA complex, however (20). Moreover, despite the fact that aspartate promotes receptor dimerization (8) and dimerization is required for the activity of the signal transducing kinase (19), aspartate binding to the Tar-CheW-CheA complex functions to inhibit kinase activity (13, 14). It has also been shown that receptors cross-linked through cysteines introduced at complimentary positions along the subunit interface between receptor monomers are still able to respond to stimuli (23, 24, 25, 26). From these results it is clear that stimulus-response coupling involves the propagation of a conformational change across the membrane within a dimeric receptor signaling complex. Thus, although dimerization is required for receptor signaling, it is not sufficient. This is consistent with results obtained with some eukaryotic receptors. The insulin receptor, for instance, naturally occurs as a disulfide-linked dimer, so at least in this case a monomer-dimer transition is not responsible for stimulus-response coupling (1, 2).

To understand the conformational change responsible for stimulus-response coupling in bacterial chemotaxis, we have attempted to reconstitute the active ternary complex using CheA, CheW, and soluble cytoplasmic fragments of the receptor. The cytoplasmic portion of the receptor contains two sequences of approximately 35 residues that are predicted to have a high propensity to form alpha -helical coiled-coil structures (27, 28). These sequences, termed MH1 and MH2, contain several specific glutamine and glutamate residues that are subject to deamidation and reversible methylation (4). Receptor signaling activity is regulated by the level of methylation/amidation (14, 22, 29). Methylation promotes kinase activation, and demethylation or deamidation, like aspartate binding, inhibits kinase activity. MH1 and MH2 flank a sequence of approximately 150 residues that has been termed the signaling domain. Genetic studies indicate that this region interacts with CheW (30).

Here we show that the aspartate receptor Tar signaling domain is in fact an independently folding unit that binds CheW. The signaling domain expressed in intact cells inhibits kinase activity, presumably by sequestering CheW from endogenous receptors. We were able to activate the kinase in cells with a construct that expressed a fragment composed of MH1 and the signaling domain. Our results are consistent with the hypothesis that MH1 helices come together in a coiled-coil to properly position the signaling domains and their associated CheW protein for formation of an active complex with CheA. This idea was corroborated by the finding that replacement of the MH1 region by a completely unrelated coiled-coil, the leucine zipper region of a transcriptional activator, produced a construct that was also able to activate the kinase. Finally, a construct generated by fusion of the transcription factor leucine zipper domain to the entire cytoplasmic region of the receptor in a position that corresponds to TM2 in the intact receptor is able to form an active complex that is regulated by glutamate modifications in much the same way as the intact receptor. The effects of constructs on receptor signaling in vivo were confirmed with purified components in vitro. These findings support a model for receptor signaling where aspartate binding controls the relative orientation of receptor monomers to favor formation of a coiled-coil between MH1 and/or MH2 within each monomer. The level of amidation and methylation of MH1 and MH2 glutamates could control the formation of these coiled-coils by neutralizing their anionic carboxylate side chains and thereby attenuating repulsive electrostatic interactions between the helical interfaces.


EXPERIMENTAL PROCEDURES

Bacterial Strains and Plasmids

Cloning and mutagenesis was carried out in DH5alpha , and overexpression of proteins from T7 promoters was done using BL21(DE3)/pLysS (31). RP437 (32) (thr(am)-1 leuB6 his-4 metF(am)159 eda-50 rpsL136 thi-1 ara-14 lacY1 mtl-1 xyl-5 tonA31 tsx-78) and RP8611 (DE7028(tsr) DE5201(tar-tap) zbd::Tn5 DE100(trg) leuB6 his-4 metF(am)159 rpsL136 thi-1 ara-14 lacY1 mtl-1 xyl-5 tonA31 tsx-78) were obtained from Dr. J. S. Parkinson. The leucine zipper fusions were constructed using pGB008 (33) obtained from Dr. R. F. Schleif.

Construction of Plasmids for Expressing Tar Fragments

The plasmids used in this study are listed in Table I, and the expressed protein fragments are outlined in Fig. 1. The genes for the cytoplasmic fragments of S. typhimurium Tar were constructed in a T7 expression vector, pT7-7 (34). An NdeI-HindIII fragment (encoding residues 257-553) from pME98 (14) was subcloned into the NdeI-HindIII sites of pT7-7 to generate pMS018. All other constructs were derived from this plasmid. This gene expresses a protein with the wild type residues at the sites of methylation (Gln295, Glu302, Gln309, Glu491 or QEQE). The all glutamate (EEEE) and all glutamine (QQQQ) derivatives were constructed by site-directed mutagenesis using standard protocols. A signaling domain (residues 315-476) expressing fragment flanked by NdeI and HindIII sites was generated by polymerase chain reaction and inserted into pT7-7 or pRSETa (Invitrogen). The genes expressing the full cytoplasmic portion of Tar were constructed by inserting a polymerase chain reaction generated NdeI fragment (encoding residues 212-257) into the NdeI site of the parent MH1-SD-MH2 clones. The final clones were confirmed by sequencing. The MH1-SD and SD-MH2 clones were constructed from EcoRV-BglII fragments of MH1-SD-MH2 plasmids and the SD plasmid (EcoRV cuts in SD coding sequence and BglII in the vector). All inserts generated by polymerase chain reaction were sequenced. For in vivo studies, the genes were moved into pUC-lac 1 (pUC19 with an EcoRI-XbaI insert encoding lacIq and lacOP). The Tar fragments were cloned on XbaI/HindIII fragments into pUC-lac1.

Table I.

Plasmids used to express fragments of Tar

Vectors and plasmid construction are described under ``Experimental Procedures.'' For details of expressed fragments see Fig. 1.
Expressed Tar fragment Modification
Plasmids
MH1 MH2 pT7-7 vector pUC-lac1 vector LZ vector

Linker-MH1-SD-MH2 QEQ E pMS055 pMS107 pMS099
Linker-MH1-SD-MH2 EEE E pMS061 pMS108 pMS106
Linker-MH1-SD-MH2 QQQ Q pMS058 pMS109 pMS105
MH1-SD-MH2 QEQ E pMS018 pUC018 pMS097
MH1-SD-MH2 EEE E pMS053 pUC053 pMS104
MH1-SD-MH2 QQQ Q pMS054 pUC054 pMS103
MH1-SD QEQ pMS018S pUC018S
MH1-SD EEE pMS053S pUC053S
MH1-SD QQQ pMS054S pUC054S
SD-MH2 E pMS018L pUC018L
SD-MH2 Q pMS054L pUC054L
SD pMS030 pUC030 pMS098
His6-SD pMS042a

a  pRSETa (Invitrogen) was the vector used for pMS042.

Plasmids expressing fusions of a leucine zipper to the N termini of the Tar fragments were constructed using pGB008 (33) which encodes residues 303-350 of C/EBP (35) cloned into the NcoI/BamHI sites of pSE380 (Invitrogen). The Tar gene fragments were excised with NdeI/HindIII and cloned into the BamHI/HindIII sites of pGB008 (the NdeI and BamHI sites were repaired with Klenow polymerase to generate blunt ends). The final constructs encode a ~38-residue coiled-coil motif connected via a flexible linker sequence (PESSLGS) to the Tar fragment.

In Vivo Swimming Behavior and Swarm Assays

To determine steady state swimming behavior, strains were grown in Tryptone medium (1.3% Tryptone (Bacto), 0.7% NaCl, pH 7.5) to late exponential growth (A600 nm ~ 0.8) at 30 °C in a shaking water bath. Cells were diluted into motility buffer (10 mM potassium phosphate, pH 7.0, 67 mM NaCl, 0.1 mM EDTA, 0.2% glycerol) for RP437 or back into Tryptone medium for RP8611 strains. Cells were videotaped under a dark field microscope, and the duration of swim intervals (for RP437 strains) or the number of tumbles per 5-s interval (for RP8611 strains) were determined by visual analysis. For the RP437 strains, the diluted cells were incubated for at least 30 min before recording swimming behavior. At least 200 swim intervals were analyzed for RP437 strains, and at least 50 cells were analyzed for the RP8611 strains. No change in swimming behavior was observed during analysis (3-10 min), indicating that the cells were exhibiting steady state behavior. The visual analysis used to calculate swimming behavior is biased against multiple tumbles with short swim intervals and therefore consistently overestimates mean swim lengths.

Expression levels of the different fragments were estimated relative to the level of CheY by Western blotting. Total cell protein was separated on 15% SDS-PAGE gels and transferred to nitrocellulose. Affinity-purified CheY rabbit antibody and affinity purified SD rabbit antibody were used to probe the blots and 125I-labeled goat anti-rabbit IgG used as secondary antibody. Signaling domain-specific antibody was purified from Tar polyclonal antibody using the His6-SD construct (36). The Tar fragments were all expressed to approximately equal levels in both strains.

Purification and Characterization of Proteins

CheA (37), CheY (38), CheZ (39), and CheW (40) were purified as described previously. The His6-SD fusion protein was purified using Ni-NTA resin (Qiagen) according to the manufacturer's instructions. MH1-SD-MH2 Tar constructs with and without leucine zippers were purified from overexpressing strains as follows. All steps were performed at 0-4 °C. Cleared cell lysates were prepared by centrifugation of sonicated cell suspensions in buffer I (50 mM Tris-HCl, 25 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, pH 7.5) first at 6000 × g for 10 min followed by 100,000 × g for 60 min. Ammonium sulfate was added to supernatants to 25% saturation (35% for the signaling domain construct), and the precipitates were collected by centrifugation at 7500 × g for 15 min and resuspended in buffer I. After centrifugation at 7500 × g for 15 min to remove any insoluble material, the ammonium sulfate precipitation procedure was repeated. The resulting protein solutions were then dialyzed against 3 × 100 volumes of buffer I and loaded onto DEAE-Sephacel (Pharmacia) equilibrated in buffer I. The column was developed with a linear gradient of 50 to 500 mM NaCl in buffer I. The peak fractions were pooled, concentrated to ~2 mg/ml in a Centriprep-10 (Amicon), and loaded over a Bio-Gel A column (Bio-Rad) in buffer I. The peak fractions were pooled, concentrated to ~2 mg/ml in a Centriprep-10 (Amicon), and dialyzed against buffer II (25 mM Tris-HCl, 25 mM KCl, 25 mM NaCl, 5 mM potassium glutamate, 1 mM EDTA, 10% glycerol, pH 7.5). Protein concentrations were determined using the BCA assay (Pierce) and absorbance at 280 nm using calculated extinction coefficients.

For the signaling domain, an additional purification step was added between DEAE-Sephacel and Bio-Gel A. Following chromatography on DEAE-Sephacel, peak samples were pooled, ammonium sulfate was added to 25%, and the sample was loaded onto phenyl-TSK (Toyopearl) equilibrated in buffer III (25 mM PIPES-NaOH, pH 6.0, 1 mM EDTA) + 25% ammonium sulfate. The column was washed with this buffer and developed with a gradient of 25 to 0% ammonium sulfate. Fractions containing signaling domain were pooled, concentrated, and loaded onto a Bio-Gel A column as described above. Protein concentrations were determined using the BCA assay (Pierce) and absorbance at 205 nm by the method of Scopes (41).

Characterization of Purified Signaling Domain

Gel filtration chromatography was carried out using a Superose-12 column (Pharmacia) in buffer IV (25 mM sodium phosphate, 50 mM NaCl, 0.1 mM EDTA; pH 7.0) at 0.4 ml/min). Protein elution was monitored by absorbance at 220 nm. No change in elution profile was observed in buffer IV containing 500 mM NaCl. Circular dichroism spectra were obtained on a JASCO CD spectrophotometer using a path length of 0.1 cm. A 20 µM sample of signaling domain was prepared in 10 mM Tris-HCl, pH 7.0, by dialysis and dilution. Helical content was estimated from the phi 208 nm by the formula: falpha  = (phi 208 nm +4000)/-29000, where phi  is the molar ellipticity (° cm2 dmol-1) and falpha is the fraction of alpha  helix (42).

Binding Assays to His6-SD

Ni-NTA resin (Qiagen) was mixed with an excess of His6-SD in 25 mM Tris-HCl, pH 7.6, containing 160 mM KCl, 5 mM MgCl2) for 60 min at 4 °C. The resin was washed five times with 3 volumes of binding buffer. To determine the final concentration of bound His6-SD in 25 mM samples of the resin were boiled in SDS-loading buffer with 100 mM imidazole for 3 min and subjected to 15% SDS-PAGE. Protein was quantitated by dye extraction (43) using purified His6-SD as a standard. The binding reactions (30 µl) were carried out by incubating His6-SD resin with the indicated amounts of CheW for 15 min on ice. The samples were centrifuged 30 s in a microcentrifuge, the supernatant aspirated off using a micropipette tip, and the resin gently resuspended in 50 µl of binding buffer containing 0.5% Tween 20 (Sigma). The sample was centrifuged and aspirated as above, and the resin finally resuspended in 30 µl of SDS-PAGE loading buffer with 100 mM imidazole. The sample was boiled for 3 min and analyzed by 15% SDS-PAGE. Bound CheW was determined by dye extraction (43).

Assays for Kinase Activity of CheA

CheY phosphorylation was measured by incubating 2.5 µM CheA, 5 µM CheW, and 25 µM CheY ± cytoplasmic Tar fragments at 30 µM in 25 mM Tris-HCl, 10 mM MgCl2, 25 mM NaCl, 25 mM potassium glutamate, 1 mM EDTA, 10% glycerol, pH 7.5 at 25 °C. Mixtures were preincubated for 30 min and reactions were initiated by the addition of [gamma -32P]ATP (100 µM final, ~1000 cpm/pmol). Samples were quenched at the indicated times by adding to SDS-PAGE loading buffer and analyzed by 17.5% SDS-PAGE. The relative level of CheY~P was determined using a PhosphorImager (Molecular Dynamics).

Steady state rates of CheA activity were determined in a spectrophotometric assay that couples ATP hydrolysis to NADH oxidation as described previously (14, 19). Reaction mixtures (80 µl) contained 1.0 mM phosphoenolpyruvate, 0.20 mM NADH, 4 units of pyruvate kinase, 4 units of lactate dehydrogenase (Boehringer Mannheim), 5 µM CheA, 5 µM CheW (unless indicated otherwise), 50 µM CheY, 1 µM CheZ, and cytoplasmic Tar fragments at the indicated concentrations in 25 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 25 mM NaCl, 25 mM potassium glutamate, 1 mM EDTA, and 10% glycerol. Mixtures were preincubated 45-60 min, at 25 °C unless noted otherwise. Reactions were initiated by the addition of ATP to 2 mM. NADH oxidation was recorded at 340 nm in a Beckman DU-65 spectrophotometer at 2.5-s intervals. The rate of ATP hydrolysis under steady state conditions was calculated using 6220 M-1cm-1 for the extinction coefficient of NADH. Controls indicated that the rate of CheA autophosphorylation was rate-limiting, and no increase in reaction rates were observed if the preincubation times were extended beyond 45 min.


RESULTS

Effects of Signaling Domain Constructs on Kinase Activity in Vivo

Tumbly swimming behavior in E. coli is caused by the interaction of phospho-CheY with components at the flagellar motor. Tumbling frequency generally correlates with the activity of the kinase CheA that mediates the ATP-dependent phosphorylation of CheY (44). Proteins that stimulate kinase activity cause an increase in tumbly behavior, and proteins that inhibit kinase activity or increase phospho-CheY dephosphorylation cause a decrease. This effect provided a qualitative measure of the effects of aspartate receptor signaling domain constructs on kinase activity. Signaling domain constructs were engineered into multicopy vectors under the control of the lac repressor and transformed into both a chemotactically wild type strain, RP437, and a strain that is defective in the aspartate receptor and its homologues, RP8611. The wild type strain, which exhibits substantial steady state tumbling behavior, was used to determine whether a given construct inhibited either the formation or activity of CheA-CheW-receptor complexes in vivo. The receptor deficient strain cannot form active ternary complexes and therefore has insufficient kinase activity to cause tumbly behavior. It was used to examine the formation of active ternary complexes between CheA, CheW, and a given Tar construct. Both RP437 and RP8611 have wild type levels of the methyltransferase and the methylesterase that modify receptor glutamate residues. The different cytoplasmic constructs of Tar were poor substrates for these enzymes in vivo and in vitro, however.2

In wild type RP437 cells, the constructs inhibited chemotaxis by 40-80% as measured by swarm rates in soft agar. This indicates that each construct is capable of interaction with at least some component of the signaling pathway in vivo. When swimming behavior was examined in wild type RP437 cells (Table II), the signaling domain alone or with MH2 caused significant decreases in tumbling frequency, whereas no decrease in tumbling frequency was observed for the MH1-SD-expressing strain. None of the constructs caused a significant enhancement of tumbling frequency in the wild type background. The demethylating enzyme is activated by a CheA-mediated phosphorylation reaction that parallels CheY phosphorylation. This provides a negative feedback mechanism to inactivate active CheA-CheW-receptor complexes in RP437. The effect would be to damp out any increases in kinase activity caused by Tar fragments that activate the kinase. Activation of the kinase could be detected in the receptor deficient strain RP8611, where the effect of demethylation does not pertain (Table III). Signaling domain constructs with an associated MH1 region caused a dramatic increase in tumble frequency in this strain. These results are consistent with previous findings in similar experiments where the effects of E. coli serine receptor Tsr fragments on swimming behavior were determined (45).

Table II.

Tumble frequency of RP437 expressing fragments of Tar


Construct Tumble frequencya

Control 0.29  (1.0)
SD 0.16  (0.55)
MH1-SD 0.29  (1.0)
SD-MH2 0.16  (0.55)
MH1-SD-MH2 0.21  (0.72)

a  Data are given as the mean number of tumbles/s with the value relative to the vector control in parentheses.

Table III.

Tumble frequency of RP8611 expressing fragments of Tar


Construct Tumble frequencya

Control <0.01
SD 0.02
LZ-SD 0.22
MH1-SD 0.34
SD-MH2 0.04
MH1-SD-MH2 0.12
LZ-MH1-SD-MH2 0.34
LZ-linker-MH1-SD-MH2 0.42

a  Data are given as the mean number of tumbles/s.

From an analysis of receptor sequences we have proposed that MH1 and MH2 are likely to form coiled-coil structures (27, 28). It seemed likely that the ability of the MH1-SD constructs to activate the kinase was due to the formation of signaling domain dimers mediated by MH1 coiled-coil interactions. This idea is supported by the observation that signaling domain dimerization mediated by the leucine zipper dimerization domain of a eukaryotic transcription factor can function to cause kinase activation (Table III). The leucine zipper was also added to constructs that contain MH2. One explanation for the negative effect of MH2 is that it forms a coiled-coil that interacts with MH1 and thereby tends to inhibit dimer formation. If this were the case one might expect that addition of the leucine zipper motif to MH1-SD-MH2 constructs would cause them to be more efficient kinase activators. When this construct, LZ-MH1-SD-MH2, was examined it was found that addition of the leucine zipper did in fact enhance the proteins ability to activate the kinase. The leucine zipper also facilitated kinase activation by a fragment of Tar corresponding to the entire C-terminal cytoplasmic region.

Signaling Domain as an Independently Folded Unit

The effects of signaling domain constructs on swimming behavior indicate that the signaling domain is an independently folding unit that can function either to activate or inhibit the kinase depending on the nature of flanking sequences. To further characterize the signaling domain, the protein was overexpressed and purified as a soluble species from cell free extracts by conventional chromatographic procedures. No proteolytic cleavage could be detected by Western blot analysis of cellular proteins using SDS-PAGE. During the purification, however, the protein was converted from its original 17,000 molecular weight form to a form that migrated during SDS-PAGE with an apparent molecular weight of about 15,500. This is probably due to C-terminal proteolysis, since sequence analysis showed that the N terminus was intact. The CD spectra of the purified signaling domain has minima at 220 and 208 nm, characteristic of alpha -helical secondary structure elements, and is predicted to be approximately 50% alpha -helical (Fig. 2). The ratio of the molar ellipticity 220 nm/208 nm is low, however. This is frequently observed for helical peptides with little or no interhelical interactions (46), suggesting that the SD may be composed of predominantly solvent-exposed helices. Recent proton exchange NMR experiments are consistent with this interpretation (47). The protein eluted during molecular sieve chromatography as a single peak with an apparent molecular weight of 60,000. Although this is considerably larger than the expected value of 18,000 for the monomeric species, it seems likely that the signaling domain is in fact a monomer. The MH1-SD-MH2 construct which is a 31,000 molecular weight monomer, elutes during molecular sieve chromatography with an apparent molecular weight of 90,000-110,000 (48, 49). Moreover, in parallel studies we have performed with the LZ-MH1-SD-MH2 construct, two forms were detected with apparent molecular weights of 130,000 and 220,000, presumably corresponding to the monomer and dimer.


Fig. 2. Characterization of purified signaling domain. A, the circular dichroism spectrum of SD in 10 mM Tris-HCl pH 7.0. The estimated alpha -helix content is ~50%. B, gel filtration chromatography of purified signaling domain on Superose-12 (Pharmacia). The SD eluted with an apparent molecular weight of ~60,000. The elution times of standards are indicated in the plot of molecular weight versus retention time (amylase, alcohol dehydrogenase, bovine serum albumin, carbonic anhydrase, and trypsin inhibitor with molecular weights of 200,000, 150,000, 66,000, 29,000, and 21,000, respectively).
[View Larger Version of this Image (13K GIF file)]

Interaction of the signaling domain with CheW and CheA was assayed by affinity chromatography (Fig. 3). Histidine-tagged SD was coupled to Ni-NTA resin and used to probe for interactions with the Che proteins. Binding of CheW to the signaling domain in a 1:1 complex was readily observed by this method. This level of binding was not affected by the degree of saturation of the resin with the histidine-tagged signaling domain, suggesting that the complex represents monomer-monomer interactions. Very little if any CheA binding was observed either in the presence or absence of CheW (<10% that of CheW binding). These results suggest that bivalent interactions are required for high affinity binding of CheA to the CheW-signaling domain complex.


Fig. 3. CheW binds specifically to the signaling domain of Tar. A, fraction of bound CheW-His6-SD complex plotted against total CheW. The results represent the average of three independent experiments. B, Coomassie Blue-stained SDS-polyacrylamide gel showing CheW that bound to His6-SD resin and control resin saturated with bovine serum albumin (see ``Experimental Procedures.'')
[View Larger Version of this Image (21K GIF file)]

Reconstitution of Signal Domain Activity with Purified Components

To further characterize the signaling domain-mediated regulation of kinase activity, the MH1-SD-MH2 and LZ-MH1-SD-MH2 constructs were purified and their effects on kinase activity assayed in the presence of CheW. Reactions were initiated by addition of [gamma -32P]ATP, and phosphorylation of CheY was measured (Fig. 4). The addition of MH1-SD-MH2 without an attached leucine zipper had no effect on kinase activity. A low level of CheY~P was formed in the presence or absence of this Tar construct, and this activity was not affected by addition of CheW. CheA~P could not be detected since CheA autophosphorylation was limiting. As has been shown previously (48), the purified MH1-SD-MH2 protein is a monomer under these conditions. In contrast, the dimeric LZ-MH1-SD-MH2 construct caused a dramatic CheW-dependent stimulation of kinase activity such that CheY was readily phosphorylated to stoichiometric levels and CheA~P began to accumulate. Clearly the addition of the leucine zipper dimerization domain to the receptor construct resulted in a substantial activation of the kinase through the formation of a ternary complex with CheW and CheA. This result tends to confirm the supposition that binary interactions are required for the association of CheA and CheW with Tar signaling domain constructs.


Fig. 4. Addition of a leucine zipper to the cytoplasmic domain of Tar results in the activation of CheA kinase in vitro. CheA (2.5 µM), CheW (5 µM), and CheY (25 µM) were preincubated 30 min at 25 °C in the absence or presence of MH1-SD-MH2 (30 µM) or LZ-MH1-SD-MH2 (30 µM). Reactions were initiated by the addition of [gamma -32P]ATP, and samples were removed and stopped at 10, 20, 30, and 40 s. The proteins were separated on 17.5% SDS-PAGE gels. The position of phosphorylated CheA and CheY are indicated on the right of the autoradiograph.
[View Larger Version of this Image (33K GIF file)]

A spectrophotometric ATPase assay was used to better quantitate the degree of kinase stimulation (Fig. 5). Conditions were adjusted so that CheA autophosphorylation was rate-limiting. The results indicated a 30-fold increase in rate of autophosphorylation in the presence of LZ-MH1-SD-MH2 and CheW. These data underestimate the activity of CheA in complexes, since a substantial fraction of the kinase is still free in solution. We have been unable to reach saturating levels of receptor fragments in this assay, because at higher levels of the protein, insoluble aggregates form. The degree of stimulation is similar, however, to that which has been observed with intact receptors in membranes.


Fig. 5. Activation of steady state kinase activity by LZ-MH1-SD-MH2. Steady state rates of CheA (5.0 µM) autophosphorylation were measured in a coupled spectrophotometric assay in presence of CheY (50 µM), CheZ (1.0 µM), CheW (5.0 µM), and LZ-MH1-SD-MH2 at 0 µM (open circle ), 12.5 µM (black-diamond ), 25 µM (black-triangle), and 50 µM (bullet ). Mixtures were preincubated at 25 °C for 45 min and reactions initiated by the addition of ATP as described under ``Experimental Procedures.'' Under the conditions used here CheA autophosphorylation is rate-limiting.
[View Larger Version of this Image (19K GIF file)]

Formation of active ternary complexes between CheA, CheW, and intact receptors in membranes has been shown to be a relatively slow process that occurs over a time course of several minutes (20). Similar times were required for the formation of active complexes with the LZ-MH1-SD-MH2 receptor construct. Kinase activation required preincubation of the construct with both CheA and CheW with maximal activity being attained after a period of 30 min (Fig. 6A). As has previously been observed with intact receptors (14), the formation of active LZ-MH1-SD-MH2 complexes increases with increasing CheW concentration up to a maximum and then decreases dramatically at higher levels. In this soluble system the optimal concentration of CheW was equimolar with CheA. This differs somewhat with the membrane system where a significant molar excess of CheW over CheA was optimal (14, 20), although significant differences in the two assays make direct comparisons difficult to interpret. The inhibitory effect of higher concentrations of CheW has been explained (14) by the supposition that at normal levels CheW functions to sandwich together CheA and the receptor signaling domain through nonoverlapping CheA and signaling domain binding sites. At sufficiently high concentrations, both CheA and the signaling domain would be independently saturated with CheW, thereby inhibiting the requisite ternary interactions. A corollary of this view is that elevated concentrations of CheW should inhibit the formation of ternary complexes but not affect their dissociation. Thus, the rate of loss of kinase activity following a large increase in CheW concentration should provide a measure of the rate of ternary complex dissociation. When this experiment was performed (Fig. 6B), an exponential decrease in kinase activity was observed, t1/2 ~ 30 min, with an initial rate that was nearly equal to the initial rate of complex formation. This result tends to confirm previous findings with the intact membrane bound receptor (20) that the steady state level of active ternary complexes observed under a given set of conditions represents an equilibrium between complex assembly and disassembly, both of which are relatively slow processes occurring over periods of minutes.


Fig. 6. The rate of ternary complex formation and dissociation in vitro. A, rate of ternary complex formation. CheA (2.5 µM), CheW (2.5 µM), CheY (50 µM), CheZ (1.0 µM), and LZ-MH1-SD-MH2 (25 µM) were incubated for the indicated times at 25 °C and kinase activity were determined by measuring ATPase activity in a coupled assay (see ``Experimental Procedures''). B, stability of the ternary complex in vitro determined by challenge with excess CheW. Complex was formed at 25 °C for 45 min. CheW was added to 25 µM and kinase activity was measured at the indicated times. No activation of kinase was observed if CheW was added at 25 µM initially. The rates are expressed as a fraction of the maximum rate measured (30 µmol of ATP/min/µmol of CheA).
[View Larger Version of this Image (12K GIF file)]

The Effect of Glutamate Modifications in MH1 and MH2 on the Regulation of Kinase Activity

Four glutamates in Tar have been shown to be potential sites of modification, three in MH1 and one in MH2 (for review, see Ref. 4). Two of these, the first and third sites in MH1, are encoded as glutamines in the wild type tar gene. Conversion of these glutamines to glutamates either by mutagenesis or through the action of the CheB esterase/amidase enzyme produces a form of Tar that suppresses tumbling in vivo (29) and forms an inactive ternary complex in vitro (14, 22). This is termed the all E form of the receptor. In contrast, conversion of the two unmodified glutamates to glutamines by mutagenesis (the all Q form), or to glutamyl methylesters through the action of the CheR methyltransferase, produces a form of the receptor that promotes tumbling in vivo (29) and forms a highly active ternary complex in vitro (14, 22). The wild type receptor, i.e. the QEQE form, has intermediate activities both in vivo and in vitro. We have observed similar effects of glutamate modification on the tumble-promoting and kinase-activating effects of MH1-SD-MH2 constructs. In general, any construct derived from the wild type QEQE receptor that promoted tumbling in intact cells had a reduced effect in its all E form and an enhanced effect in its all Q form (Table IV). Similar results were obtained in vitro with purified LZ-MH1-SD-MH2 fragments (Table V). MH1-SD-MH2 fragments without an associated leucine zipper domain did not activate the kinase in vitro under these conditions, whatever their state of glutamyl modification.

Table IV.

Tumble frequency of RP8611 expressing fragments of Tar with different levels of modification

Tumble frequency is expressed relative to the unmodified form of the protein with the actual tumble frequencies (s-1) given in parentheses. The modification at the sites of methylation are indicated above each column. The first three positions correspond to MH1 and the fourth position to MH2.
Receptor fragment Relative tumble frequency modification
All E Wild type (QEQE) All Q

MH1-SD 0.2 1 1.2
(0.34)
SD-MH2 1 1
(0.04)
MH1-SD-MH2 0.1 1 3.2
(0.12)
LZ-MH1-SD-MH2 0.5 1 3.3
(0.34)
LZ-Linker-MH1-SD-MH2 0.4 1 1.6
(0.42)

Table V.

Activation of CheA kinase in vitro is regulated by level of receptor modification


Construct Modification Activitya

µmol/min/µmol
Control 2.0
LZ-MH1-SD-MH2 All E 1.5
Wild type 35.5
All Q 71.0

a  Steady state rates of kinase activity were measured in a coupled spectrophotometric assay with 4 µM CheA, 5 µM CheW, and 30 µM Tar fragment as described under ``Experimental Procedures.''


DISCUSSION

The aspartate receptor, Tar, belongs to a large family of membrane receptor transducer proteins that interact with CheA and CheW proteins to provide sensory inputs that control the chemotactic responses of bacteria (for a review, see Ref. 4). These receptors, termed methyl-accepting chemotaxis proteins or MCPs, are characterized by a highly conserved cytoplasmic signaling domain, SD, flanked by regions that contain glutamine or glutamate residues that are subject to deamidation, methylation, and demethylation contained in sequences that are predicted to form alpha -helical coiled-coil structures, MH1 and MH2. Here we show that the signaling domain is an independently folded unit that binds CheW. We find no evidence for a significant interaction between the signaling domain and CheA. Previous genetic and biochemical results have indicated that this portion of the serine receptor Tsr, which has an almost identical signaling domain, interacts with the CheA protein to suppress tumbly behavior in vivo and inhibit the kinase in vitro (45). The results with Tsr SD constructs were obtained at concentrations at least an order of magnitude above those used here, however, and mutant forms of the protein were used that had been selected for their ability to suppress tumbling behavior.

It has previously been shown that the Tsr-SD with an associated MH1 coiled-coil sequence stimulates tumbly behavior in vivo, and together with CheW activates CheA kinase in vitro (45). We have obtained similar results with a corresponding fragment of Tar, the MH1-SD construct. It seems likely that the activity of this receptor fragment depends on the potential of the coiled-coil region to facilitate the formation of SD dimers. A weak 1:1 interaction between CheA and CheW has been detected, KD = 20 µM (20). Since CheW is monomeric at micromolar concentrations (20) and CheA is dimeric (19, 21), assuming independent binding sites for CheW on CheA and SD, one would predict that a monomeric SD-complex would have a KD of 20 µM for CheA, whereas a dimeric SD-CheW complex would have a KD for CheA significantly lower than 20 µM. The supposition that dimerization greatly facilitates complex formation was confirmed by the finding that a leucine zipper coiled-coil dimerization domain can act in place of the MH1 sequence to facilitate tumbling behavior. The use of coiled-coil domains as engineered dimerization motifs has been successfully applied to several eukaryotic receptors (50, 51, 52).

Activation of the signaling domain using either MH1 or a leucine zipper motif suggests that the MH1 regions are positioned in such a way as to allow the formation of an active complex. This tends to confirm the notion that there is an interaction of MH1 regions from both monomers in the native receptor dimer. Our results suggest that MH1-MH1' interactions in the receptor dimer may be regulated by interactions with MH2/MH2'. Both MH1 and MH2 score with probabilities greater than 50% when analyzed with programs that are designed to predicted coiled-coil structures (27, 53). Tar receptor fragments that contain both the MH1- and MH2-flanking regions are less efficient in promoting tumbly behavior or activating the kinase then MH1-SD fragments or constructs with an associated leucine zipper dimerization domain. Moreover, SD-MH2 fragments, as shown here with Tar, or previously with Tsr (45), fail to promote tumbly behavior in vivo. These results are consistent with our previous proposal (28) that MH2 can fold back to make intramolecular helical interactions thereby forming four helix bundles in intact receptor dimers. One might expect that such MH1-MH2 intramolecular contacts would attenuate the propensity for the MH1 intermolecular interactions that presumably cause dimerization of monomeric MH1-SD fragments.

We have previously proposed that methylation or amidation controls the orientation of subunits within multimeric receptor complexes by modulating electrostatic interactions between MH1 and MH2 coiled-coil sequences (28). The observations reported here for the effects of glutamate to glutamine mutagenesis are consistent with this view. The finding that even MH1-SD-MH2 constructs with an associated leucine zipper motif modulate kinase activity in response to glutamate modification much as do receptors in membranes suggests that the conformational effects of these modifications can occur independently of the transmembrane or periplasmic portions of the proteins.

The formation of active ternary complexes between CheA, CheW, and the receptor is a complex process. Coiled-coil sequences are known to participate in different types of assemblies and can form dynamic structures which readily exhibit transitions between multiple forms (54, 55). It has been well established that coiled-coil transitions play important roles in controlling the activities of transcription factors, cytoskeletal elements, and many different types of activities of membrane proteins such as alpha -hemaglutinin. Our results suggest that the dynamic nature of these structures can also play a central role in modulating the transmembrane signaling activities of chemotaxis receptors in bacteria. Reconstituting the activated and adapted states of the chemotaxis receptors in a soluble system with defined components means that an analysis of this dynamic system can now be accomplished using a combination of well established biophysical methods.


FOOTNOTES

*   This work was supported by National Institutes of Health Grant AI20980 (to J. B. S.). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed. Tel.: 609-258-6111; Fax: 609-258-6175; E-mail: jstock{at}watson.princeton.edu.
1   The abbreviations used are: Tar, receptor for taxis to aspartate and repellents; TM1, transmembrane segment 1; TM2, transmembrane segment 2; MH1, methylated helix 1; MH2, methylated helix 2; SD, signaling domain; LZ, leucine zipper; MCP, methyl accepting chemotaxis protein; Tsr, receptor for taxis to serine and repellents; PIPES, 1,4-piperazinediethanesulfonic acid.
2   M. G. Surette and J. B. Stock, unpublished results.

Note Added in Proof

Cochran and Kim (Cochran, A. G., and Kim, P. S. (1996) Science 271, 1113-1116) have recently reported kinase activation by a leucine zipper-Tar construct where a leucine zipper dimerization domain is fused to MH1 (analogous to our LZ-MH1-SD-MH2 constructs). They found that the phasing of the leucine zipper helix with respect to MH1 was important for activation and/or complex formation. In our leucine zipper constructs a flexible linker has been engineered between the leucine zipper and the indicated Tar fragment so that phasing is presumably not an issue.


REFERENCES

  1. Ullrich, A., Schlessinger, J. (1990) Cell 61, 203-212 [CrossRef][Medline] [Order article via Infotrieve]
  2. Heldin, C.-H. (1995) Cell 80, 213-223 [CrossRef][Medline] [Order article via Infotrieve]
  3. DeVos, A. M., Ultsch, M., Kossiakoff, A. A. (1992) Science 255, 306-312 [Abstract/Free Full Text]
  4. Stock, J. B., Surette, M. (1996) Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology (Neidhardt, F. C., eds) , 2nd Ed. , p. 1103, American Society for Microbiology, Washington, D. C.
  5. Kim, S.-H. (1994) Protein Sci. 3, 159-165 [Abstract]
  6. Parkinson, J. S. (1993) Cell 73, 857-871 [CrossRef][Medline] [Order article via Infotrieve]
  7. Hazelbauer, G. L. (1992) Curr. Opin. Struct. Biol. 2, 505-510 [CrossRef]
  8. Milligan, D. L., Koshland, D. E., Jr. (1988) J. Biol. Chem. 263, 6268-6275 [Abstract/Free Full Text]
  9. Milburn, M. V., Prive, G. G., Milligan, D. L., Scott, W. G., Yeh, J., Jancarik, J., Koshland, D. E. J., Kim, S.-H. (1991) Science 254, 1342-1347 [Abstract/Free Full Text]
  10. Yeh, J. I., Biemann, H. P., Pandit, J., Koshland, D. E., Kim, S.-H. (1993) J. Biol. Chem. 268, 9787-9792 [Abstract/Free Full Text]
  11. Scott, W. G., Milligan, D. L., Milburn, M. V., Prive, G. G., Yeh, J., Koshland, D. E. J., Kim, S.-H. (1993) J. Mol. Biol. 232, 555-573 [CrossRef][Medline] [Order article via Infotrieve]
  12. Pakula, A. A., Simon, M. I. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 4144-4148 [Abstract/Free Full Text]
  13. Borkovich, K. A., Kaplan, N., Hess, J. F., Simon, M. I. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 1208-1212 [Abstract/Free Full Text]
  14. Ninfa, E. G., Stock, A., Mowbray, S., Stock, J. (1991) J. Biol. Chem. 266, 9764-9770 [Abstract/Free Full Text]
  15. Swanson, R. V., Schuster, S. C., Simon, M. I. (1993) Biochemistry 32, 7623-7629 [CrossRef][Medline] [Order article via Infotrieve]
  16. Parkinson, J. S., Kofoid, E. C. (1992) Annu. Rev. Genet. 26, 71-112 [CrossRef][Medline] [Order article via Infotrieve]
  17. Wolfe, A. J., Stewart, R. C. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1518-1522 [Abstract/Free Full Text]
  18. Swanson, R. V., Bourret, R. B., Simon, M. I. (1993) Mol. Microbiol. 8, 435-441 [CrossRef][Medline] [Order article via Infotrieve]
  19. Surette, M., Levit, M., Liu, Y., Lukat, G., Ninfa, E., Ninfa, A., Stock, J. (1996) J. Biol. Chem. 271, 939-945 [Abstract/Free Full Text]
  20. Gegner, J. A., Graham, D. R., Roth, A. F., Dahlquist, F. W. (1992) Cell 18, 975-982
  21. Gegner, J. A., Dahlquist, F. W. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 750-754 [Abstract/Free Full Text]
  22. Borkovich, K. A., Alex, L. A., Simon, M. I. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6756-6760 [Abstract/Free Full Text]
  23. Chervitz, S. A., Falke, J. J. (1995) J. Biol. Chem. 270, 24043-24053 [Abstract/Free Full Text]
  24. Chervitz, S. A., Lin, C. M., Falke, J. J. (1995) Biochemistry 34, 9722-9733 [CrossRef][Medline] [Order article via Infotrieve]
  25. Lee, G. F., Lebert, M. R., Lilly, A. A., Hazelbauer, G. L. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3391-3395 [Abstract/Free Full Text]
  26. Lee, G. F., Dutton, D. P., Hazelbauer, G. L. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5416-5420 [Abstract/Free Full Text]
  27. Lupas, A., VanDyke, M., Stock, J. (1991) Science 252, 1162-1164 [CrossRef][Medline] [Order article via Infotrieve]
  28. Stock, J. B., Lukat, G. S., Stock, A. M. (1991) Annu. Rev. Biophys. Biophys. Chem. 20, 109-136 [CrossRef][Medline] [Order article via Infotrieve]
  29. Springer, M. S., Goy, M. F., Adler, J. (1979) Nature 280, 279-284 [CrossRef][Medline] [Order article via Infotrieve]
  30. Liu, J., Parkinson, J. S. (1991) J. Bacteriol. 173, 4941-4951 [Abstract/Free Full Text]
  31. Studier, F. W., Moffatt, B. A. (1986) J. Mol. Biol. 189, 113-130 [CrossRef][Medline] [Order article via Infotrieve]
  32. Parkinson, J. S. (1978) J. Bacteriol. 135, 45-53 [Abstract/Free Full Text]
  33. Bustos, S. A., Schleif, R. F. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 5638-5642 [Abstract/Free Full Text]
  34. Tabor, S., Richardson, C. C. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 1074-1078 [Abstract/Free Full Text]
  35. Landshulz, W. W., Johnson, P. F., Adashi, E. Y., Graves, B. J., McKnight, S. L. (1988) Genes Dev. 2, 786-800 [Abstract/Free Full Text]
  36. Gu, J., Stephenson, C. G., Iadorola, M. J. (1994) BioTechniques 17, 257-262 [Medline] [Order article via Infotrieve]
  37. Stock, A., Chen, T., Welsh, D., Stock, J. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 1403-1407 [Abstract/Free Full Text]
  38. Stock, A., Koshland, D. E., Jr., Stock, J. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 7989-7993 [Abstract/Free Full Text]
  39. Stock, A. M., Stock, J. B. (1987) J. Bacteriol. 169, 3301-3311 [Abstract/Free Full Text]
  40. Stock, A., Mottonen, J., Chen, T., Stock, J. (1987) J. Biol. Chem. 262, 535-537 [Abstract/Free Full Text]
  41. Scopes, R. K. (1974) Anal. Biochem. 59, 277-282 [CrossRef][Medline] [Order article via Infotrieve]
  42. Copeland, R. A. (1994) Methods for Protein Analysis: A Practical Guide to Laboratory Protocols , p. 195, Chapman & Hall, New York
  43. Ball, E. H. (1986) Anal. Biochem. 155, 23-27 [CrossRef][Medline] [Order article via Infotrieve]
  44. Bray, D., Bourret, R. B., Simon, M. I. (1993) Mol. Biol. Cell 4, 469-482 [Abstract]
  45. Ames, P., Parkinson, J. S. (1994) J. Bacteriol. 176, 6340-6348 [Abstract/Free Full Text]
  46. Monera, O. D., Zhou, N. E., Kay, C. M., Hodges, R. S. (1993) J. Biol. Chem. 268, 19218-19227 [Abstract/Free Full Text]
  47. Seeley, S. K., Weis, R. M., Thompson, L. K. (1994) Biophys. J. 66, A172
  48. Long, D. G., Weis, R. M. (1992) Biochemistry 31, 9904-9911 [CrossRef][Medline] [Order article via Infotrieve]
  49. Kaplan, N., Simon, M. I. (1988) J. Bacteriol. 170, 5134-5140 [Abstract/Free Full Text]
  50. Chang, H.-C., Bao, Z.-Z., Yao, Y., Tse, A. G. D., Goyarts, E. C., Madsen, M., Kawasaki, E., Brauer, P. P., Sacchettini, J. C., Nathenson, S. G., Reinherz, E. L. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11408-11412 [Abstract/Free Full Text]
  51. Muir, T. W., Williams, M. J., Ginsberg, M. H., Kent, S. B. H. (1994) Biochemistry 33, 7701-7708 [CrossRef][Medline] [Order article via Infotrieve]
  52. Wu, Z., Eaton, S. F., Laue, T. M., Johnson, K. W., Sana, T. S., Ciardelli, T. L. (1994) Protein Eng. 7, 1137-1144 [Abstract/Free Full Text]
  53. Berger, B., Wilson, D. B., Wolf, E., Tonchev, T., Milla, M., Kim, P. S. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8259-8263 [Abstract/Free Full Text]
  54. Harbury, P. B., Zhang, T., Kim, P. S., Alber, T. (1993) Science 262, 1401-1407 [Abstract/Free Full Text]
  55. Lovejoy, B., Choe, S., Cascio, D., McRorie, D. K., DeGrado, W. F., Eisenberg, D. (1993) Science 259, 1288-1293 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
P. Ames, Q. Zhou, and J. S. Parkinson
Mutational Analysis of the Connector Segment in the HAMP Domain of Tsr, the Escherichia coli Serine Chemoreceptor
J. Bacteriol., October 15, 2008; 190(20): 6676 - 6685.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. L. Budyak, V. Pipich, O. S. Mironova, R. Schlesinger, G. Zaccai, and J. Klein-Seetharaman
Shape and oligomerization state of the cytoplasmic domain of the phototaxis transducer II from Natronobacterium pharaonis
PNAS, October 17, 2006; 103(42): 15428 - 15433.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. M. Wolanin, M. D. Baker, N. R. Francis, D. R. Thomas, D. J. DeRosier, and J. B. Stock
Self-assembly of receptor/signaling complexes in bacterial chemotaxis
PNAS, September 26, 2006; 103(39): 14313 - 14318.
[Abstract] [Full Text] [PDF]